Abstract

Clinical Outcomes After Personalized Dosimetry for 90Y Radioembolization of Advanced Hepatocellular Carcinoma: Defining the Role of a Device in a Pharma-Centric Landscape.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Abstract CT210: Phase Ib/II study of sorafenib (SOR) and pembrolizumab (PEM) in patients (pts) with advanced hepatocellular carcinoma (HCC)
Renuka Iyer ... Devalingam Mahalingam
American Journal of Cancer | VOL. 84
Renuka Iyer, et. al.Renuka Iyer ... Devalingam Mahalingam
05 Apr 2024
A study of pembrolizumab (pembro) in combination with Y90 radioembolization in patients (pts) with poor prognosis hepatocellular carcinoma (HCC) with preserved liver function.
Autumn Jackson Mcree ... Matthew Johnson
Journal of Clinical Oncology | VOL. 40
Autumn Jackson Mcree, et. al.Autumn Jackson Mcree ... Matthew Johnson
01 Feb 2022
Phase 2/3 study of livmoniplimab in combination with budigalimab in patients with locally advanced or metastatic hepatocellular carcinoma.
Ghassan K Abou-Alfa ... Cristiano Ferlini
Journal of Clinical Oncology | VOL. 42
Ghassan K Abou-Alfa, et. al.Ghassan K Abou-Alfa ... Cristiano Ferlini
01 Jun 2024
An open-label, multicenter study investigating RP3 oncolytic immunotherapy in combination with first- or second-line systemic atezolizumab and bevacizumab therapy in patients with locally advanced unresectable or metastatic hepatocellular carcinoma.
Tanios S Bekaii-Saab ... Muneeb Ahmed
Journal of Clinical Oncology | VOL. 41
Tanios S Bekaii-Saab, et. al.Tanios S Bekaii-Saab ... Muneeb Ahmed
01 Feb 2023
View more papers

More From: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Paper Title
Journal
Date
Author
Fibroblast Activation Protein-Directed Imaging Outperforms 18F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial.
Lukas Kessler ... Hubertus Hautzel
Journal of nuclear medicine : official publication, Society of Nuclear Medicine | VOL. -
Lukas Kessler, et. al.Lukas Kessler ... Hubertus Hautzel
03 Jul 2024
An International Study of Factors Affecting Variability of Dosimetry Calculations, Part 3: Contribution from Calculating Absorbed Dose from Time-Integrated Activity.
Julia Brosch-Lenz ... Carlos Uribe
Journal of nuclear medicine : official publication, Society of Nuclear Medicine | VOL. -
Julia Brosch-Lenz, et. al.Julia Brosch-Lenz ... Carlos Uribe
03 Jul 2024
Dosimetry of [177Lu]Lu-PSMA-Targeted Radiopharmaceutical Therapies in Patients with Prostate Cancer: A Comparative Systematic Review and Metaanalysis.
Zachary Ells ... Jeremie Calais
Journal of nuclear medicine : official publication, Society of Nuclear Medicine | VOL. -
Zachary Ells, et. al.Zachary Ells ... Jeremie Calais
03 Jul 2024
Performing [18F]MFBG Long-Axial-Field-of-View PET/CT Without Sedation or General Anesthesia for Imaging of Children with Neuroblastoma.
Lise Borgwardt ... Barbara Malene Fischer
Journal of nuclear medicine : official publication, Society of Nuclear Medicine | VOL. -
Lise Borgwardt, et. al.Lise Borgwardt ... Barbara Malene Fischer
03 Jul 2024
View more papers